The Readout Loud

The Readout Loud

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Denne podkasten er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(417)

388: The FDA's refusal to review Moderna's mRNA flu vaccine

388: The FDA's refusal to review Moderna's mRNA flu vaccine

We’re devoting our entire episode this week to one controversial and impactful topic: the FDA’s decision to block the review of Moderna’s mRNA flu shot. STAT was the first to report that Vinay Prasad...

12 Feb 51min

387: Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s

387: Challenges for a crucial sickle cell treatment and the latest outlook for GLP-1s

On this week’s episode of The Readout LOUD: two starkly different financial outlooks from Novo Nordisk and Eli Lilly, a psychedelics drug from Compass Pathways encountered a roadblock with the Trump W...

5 Feb 28min

From Drug Story: Lipitor and Heart Disease

From Drug Story: Lipitor and Heart Disease

This is an episode of Drug Story, a podcast by Thomas Goetz. You can find the rest of the series at https://www.drugstory.co/podcast Once you turn 40, it seems like half the people you know are takin...

3 Feb 1h 1min

386: The high stakes for Huntington's patients

386: The high stakes for Huntington's patients

Biotech company UniQure is set to meet with the Food and Drug Administration to discuss the path forward for its gene therapy for Huntington's disease, and the outcome could be potentially devastating...

29 Jan 41min

385: A measles outbreak and hospitals' financial troubles

385: A measles outbreak and hospitals' financial troubles

Why is the U.S. at risk of losing its measles elimination status? How are health officials reacting to the measles outbreak? And what did top Centers for Medicare and Medicaid Services official Mehmet...

22 Jan 29min

384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen

384: Live from the JP Morgan conference, a sit-down with Novo Nordisk's CEO and VC Bob Nelsen

For this very special episode of The Readout LOUD Allison, Adam, and Elaine are live from the J.P. Morgan Healthcare Conference in San Francisco. The hosts are joined by ARCH Venture Partners co-foun...

14 Jan 1h 8min

383: JPM to bring more deals and happy CEOs

383: JPM to bring more deals and happy CEOs

What news happened over the holidays? Why will pharma CEOs be greeted warmly in San Francisco next week? And who will buy Revolution Medicines? We discuss all that and more on this week’s episode of ...

8 Jan 33min

382: Biotech's year in review

382: Biotech's year in review

Is the biotech industry truly out of its slump? Why are employers dropping coverage of weight loss drugs? And what will the hosts bake for the holidays? We discuss all that and more on this week's ep...

18 Des 202534min

Populært innen Business og økonomi

stopp-verden
dine-penger-pengeradet
e24-podden
rss-penger-polser-og-politikk
lydartikler-fra-aftenposten
rss-borsmorgen-okonominyhetene
rss-skravla-gar
rss-pa-konto
pengepodden-2
rss-orjasater
utbytte
livet-pa-veien-med-jan-erik-larssen
finansredaksjonen
tid-er-penger-en-podcast-med-peter-warren
pengesnakk
stormkast-med-valebrokk-stordalen
lederpodden
morgenkaffen-med-finansavisen
liberal-halvtime
rss-markedspuls-2